Gennex Laboratories Limited specializes in manufacturing and exports active pharmaceutical ingredients (APIs) and intermediates, focusing on expectorants, muscle relaxants, analgesics, and antifungal products.

The company maintains a global footprint with exports to countries including Germany, UK, Spain, Singapore, Canada, and more, marking its prominence in international markets.

It has a vertically integrated business model, enhancing operational efficiencies and product diversification.

In 2023, Gennex acquired a 51% share in Deccan Remedies Limited, indicating a strategic move to expand its business scope.

The company emphasizes compliance with GMP standards and CGMP guidelines, showcasing its commitment to quality and industry best practices.